Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

Journal of Experimental Medicine

Volumn 206, Issue 6, 2009, Pages 1423-1434

  Strowig, Till ^a   Gurer, Cagan ^a   Ploss, Alexander ^a   Liu, Yi Fang ^b   Arrey, Frida ^a   Sashihara, Junji ^c   Koo, Gloria ^d,e   Rice, Charles M ^a   Young, James W ^d   Chadburn, Amy ^b   Cohen, Jeffrey I ^c   Münz, Christian ^a,f  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e HOSPITAL FOR SPECIAL SURGERY   (United States)

^f INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA A2 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HERPES; HLA SYSTEM; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE; VIRUS CARRIER; VIRUS ISOLATION; VIRUS LOAD;

ANIMALS; DISEASE MODELS, ANIMAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HLA-A2 ANTIGEN; HUMANS; IMMUNE SYSTEM; KIDNEY; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; NEOPLASMS; SPLEEN; T-LYMPHOCYTES;

EID: 67449168401     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20081720     Document Type: Article

References (47)

1. Mestas, J., and C.C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172:2731-2738. (Pubitemid 38263654)
2. Waterston, R.H., K. Lindblad-Toh, E. Birney, J. Rogers, J.F. Abril, P. Agarwal, R. Agarwala, R. Ainscough, M. Alexandersson, P. An, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature. 420:520-562. (Pubitemid 35477048)
3. Young, L.S., and A.B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer. 4:757-768. (Pubitemid 39331148)
4. Cohen, J.I. 2000. Epstein-Barr virus infection. N. Engl. J. Med. 343:481-492. (Pubitemid 30646489)
5. Kelly, G.L., A.E. Milner, G.S. Baldwin, A.I. Bell, and A.B. Rickinson. 2006. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA. 103:14935-14940. (Pubitemid 44527832)
6. Babcock, G.J., D. Hochberg, and A.D. Thorley-Lawson. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity. 13:497-506. (Pubitemid 30951873)
7. Hochberg, D., J.M. Middeldorp, M. Catalina, J.L. Sullivan, K. Luzuriaga, and D.A. Thorley-Lawson. 2004. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl. Acad. Sci. USA. 101:239-244. (Pubitemid 38084234)
8. Gottschalk, S., C.M. Rooney, and H.E. Heslop. 2005. Post-transplant lymphoproliferative disorders. Annu. Rev. Med. 56:29-44. (Pubitemid 40299772)
9. Hislop, A.D., G.S. Taylor, D. Sauce, and A.B. Rickinson. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25:587-617. (Pubitemid 46697918)
10. Khanna, R., and S.R. Burrows. 2000. Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. Annu. Rev. Microbiol. 54:19-48. (Pubitemid 30835905)
11. + T cells: ready for direct attack. J. Exp. Med. 203:805-808.
12. + T-cell response. Nat. Rev. Immunol. 4:595-602.
13. Traggiai, E., L. Chicha, L. Mazzucchelli, L. Bronz, J.C. Piffaretti, A. Lanzavecchia, and M.G. Manz. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 304:104-107. (Pubitemid 38451466)
14. -/- mice: functional inactivation of p53 in developing T cells. Blood. 104:3886-3893.
15. Ishikawa, F., M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L.D. Shultz, and M. Harada. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chainnull mice. Blood. 106:1565-1573. (Pubitemid 41208567)
16. Shultz, L.D., B.L. Lyons, L.M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S.D. Gillies, M. King, J. Mangada, et al. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174:6477-6489. (Pubitemid 40663843)
17. Melkus, M.W., J.D. Estes, A. Padgett-Thomas, J. Gatlin, P.W. Denton, F.A. Othieno, A.K. Wege, A.T. Haase, and J.V. Garcia. 2006. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 12:1316-1322. (Pubitemid 44706935)
18. Fafi-Kremer, S., P. Morand, J.P. Brion, P. Pavese, M. Baccard, R. Germi, O. Genoulaz, S. Nicod, M. Jolivet, R.W. Ruigrok, et al. 2005. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. J. Infect. Dis. 191:985-989. (Pubitemid 40349816)
19. Ehlers, B., G. Dural, N. Yasmum, T. Lembo, B. de Thoisy, M.P. Ryser-Degiorgis, R.G. Ulrich, and D.J. McGeoch. 2008. Novel mammalian herpesviruses and lineages within the Gammaherpesvirinae: cospeciation and interspecies transfer. J. Virol. 82:3509-3516.
20. Fogg, M.H., D. Garry, A. Awad, F. Wang, and A. Kaur. 2006. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques. J. Immunol. 176:3391-3401. (Pubitemid 43363986)
21. + T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue. J. Virol. 79:12681-12691.
22. Wilson, A.D., M. Shooshstari, S. Finerty, P. Watkins, and A.J. Morgan. 1996. Virus-specific cytotoxic T cell responses are associated with immunity of the cottontop tamarin to Epstein-Barr virus (EBV). Clin. Exp. Immunol. 103:199-205. (Pubitemid 26045359)
23. Hochberg, D., T. Souza, M. Catalina, J.L. Sullivan, K. Luzuriaga, and D.A. Thorley-Lawson. 2004. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J. Virol. 78:5194-5204. (Pubitemid 38581471)
24. Laichalk, L.L., D. Hochberg, G.J. Babcock, R.B. Freeman, and D.A. Thorley-Lawson. 2002. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity. 16:745-754. (Pubitemid 34626694)
25. Kimura, H., Y. Hoshino, H. Kanegane, I. Tsuge, T. Okamura, K. Kawa, and T. Morishima. 2001. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 98:280-286.
26. Miyamura, T., K. Chayama, T. Wada, K. Yamaguchi, N. Yamashita, T. Ishida, K. Washio, N. Morishita, A. Manki, M. Oda, and T. Morishima. 2008. Two cases of chronic active Epstein-Barr virus infection in which EBV-specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation. Pediatr. Transplant. 12:588-592.
27. Kutok, J.L., and F. Wang. 2006. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1:375-404.
28. Knowles, D.M., E. Cesarman, A. Chadburn, G. Frizzera, J. Chen, E.A. Rose, and R.E. Michler. 1995. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 85:552-565.
29. Gurer, C., T. Strowig, F. Brilot, M. Pack, C. Trumpfheller, F. Arrey, C.G. Park, R.M. Steinman, and C. Münz. 2008. Targeting the nuclear antigen 1 of Epstein Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 112:1231-1239.
30. Yajima, M., K. Imadome, A. Nakagawa, S. Watanabe, K. Terashima, H. Nakamura, M. Ito, N. Shimizu, M. Honda, N. Yamamoto, and S. Fujiwara. 2008. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J. Infect. Dis. 198:673-682.
31. Küppers, R. 2003. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3:801-812. (Pubitemid 37328658)
32. + cells with Epstein-Barr virus. J. Virol. 78:13891-13900.
33. -/- mice as a model for Epstein-Barr virus infection. Am. J. Pathol. 173:1369-1378.
34. Münz, C. 2005. Immune response and evasion in the host-EBV interaction. In Epstein-Barr Virus. E.S. Robertson, editor. Caister Academic Press, Norfolk, VA. 197-231.
35. Zhang, L., G.I. Kovalev, and L. Su. 2007. HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood. 109:2978-2981.
36. -/- (RAG-hu) mice. Virology. 373:342-351.
37. null mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J. Virol. 81:13259-13264.
38. -/- mice. Proc. Natl. Acad. Sci. USA. 103:15951-15956.
39. An, D.S., B. Poon, R. Ho Tsong Fang, K. Weijer, B. Blom, H. Spits, I.S. Chen, and C.H. Uittenbogaart. 2007. Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin. Vaccine Immunol. 14:391-396. (Pubitemid 46732549)
40. -/- mice. J. Virol. 81:2700-2712.
41. + T cell depletion in humanized mice infected with HIV-1. J. Exp. Med. 204:705-714.
42. Van Duyne, R., J. Cardenas, R. Easley, W. Wu, K. Kehn-Hall, Z. Klase, S. Mendez, C. Zeng, H. Chen, M. Saifuddin, and F. Kashanchi. 2008. Effect of transcription peptide inhibitors on HIV-1 replication. Virology. 376:308-322.
43. Bickham, K., K. Goodman, C. Paludan, S. Nikiforow, M.L. Tsang, R.M. Steinman, and C. Münz. 2003. Dendritic cells initiate immune control of Epstein-Barr virus transformation of B lymphocytes in vitro. J. Exp. Med. 198:1653-1663. (Pubitemid 37494158)
44. + T-cell clones using peptide pulsed mature dendritic cells. J. Immunol. Methods. 258:111-126.
45. Ferlazzo, G., D. Thomas, S.L. Lin, K. Goodman, B. Morandi, W.A. Muller, A. Moretta, and C. Münz. 2004. The abundant NK cells in human lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172:1455-1462. (Pubitemid 38116788)
46. Borza, C.M., and L.M. Hutt-Fletcher. 2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 8:594-599. (Pubitemid 34633437)
47. Busch, D.H., I.M. Pilip, S. Vijh, and E.G. Pamer. 1998. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity. 8:353-362. (Pubitemid 28188895)